A study based on immunohistochemical analysis of primary tumor tissue obtained from patients with oral squamous cell carcinoma demonstrates that low expression of plectin predicts a favorable outcome for patients with non-metastatic OSCC and the expression level of plectin maybe useful in the treatment stratification for patients with early stage disease. (Source: BMC Oral Health)
MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
